We investigated whether partitioning DLCO into membrane conductance for CO (DmCO) and pulmonary capillary blood volume (Vcap) was helpful in suspecting precapillary pulmonary (arterial) hypertension (P(A)H) in systemic sclerosis (SSc) patients with or without interstitial lung disease (ILD). We included 63 SSc patients with isolated PAH (n=6), isolated ILD (n=19), association of both (n=12) or without PAH and ILD (n=26). Partitioning of DLCO was performed by the combined DLNO/DLCO method. DLCO, DmCO and Vcap were equally reduced in patients with isolated PAH and patients with isolated ILD but Vcap/alveolar volume (VA) ratio was significantly lower in the isolated PAH group. In patients without ILD, DLCO, DmCO, Vcap and Vcap/VA ratio were re...
Introduction: Patients with mean pulmonary artery pressures (mPAP) of 21 to 24 mm Hg have a so-calle...
Objective Our goal was to determine if whole blood viscosity (WBV) can be used to predict the risk o...
Background: Pulmonary involvement, manifested as pulmonary arterial hypertension or pulmonary fibros...
Abstract Background There is no optimal screening tool for the assessment of pulmonary arterial hype...
OBJECTIVES: Lung diffusing capacity for carbon monoxide (DLCO) is impaired in interstitial lung dise...
In patients with systemic sclerosis, a ratio between forced vital capacity (FVC) and diffusing capac...
Impaired diffusing capacity of the lung for carbon monoxide (DLCO) was frequently observed in system...
Early intervention in pulmonary arterial hypertension associated with systemic sclerosis (SSc) may i...
Background Impaired diffusing capacity of the lung for carbon monoxide (DLCO) was frequently observe...
The objective of this study was to evaluate the incidence of pulmonary hypertension (PH) and determi...
To measure the prevalence of different types of pulmonary hypertension (PH) and to identify patients...
OBJECTIVE: Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of death in s...
BACKGROUND: Combined diffusion capacity of the lung for carbon monoxide (DLco) and nitric oxide (DLn...
Objective: Early detection of pulmonary arterial hypertension (PAH) is crucial to improve patient ou...
Pre-capillary pulmonary hypertension (PH) in systemic sclerosis (SSc) is a heterogeneous condition w...
Introduction: Patients with mean pulmonary artery pressures (mPAP) of 21 to 24 mm Hg have a so-calle...
Objective Our goal was to determine if whole blood viscosity (WBV) can be used to predict the risk o...
Background: Pulmonary involvement, manifested as pulmonary arterial hypertension or pulmonary fibros...
Abstract Background There is no optimal screening tool for the assessment of pulmonary arterial hype...
OBJECTIVES: Lung diffusing capacity for carbon monoxide (DLCO) is impaired in interstitial lung dise...
In patients with systemic sclerosis, a ratio between forced vital capacity (FVC) and diffusing capac...
Impaired diffusing capacity of the lung for carbon monoxide (DLCO) was frequently observed in system...
Early intervention in pulmonary arterial hypertension associated with systemic sclerosis (SSc) may i...
Background Impaired diffusing capacity of the lung for carbon monoxide (DLCO) was frequently observe...
The objective of this study was to evaluate the incidence of pulmonary hypertension (PH) and determi...
To measure the prevalence of different types of pulmonary hypertension (PH) and to identify patients...
OBJECTIVE: Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of death in s...
BACKGROUND: Combined diffusion capacity of the lung for carbon monoxide (DLco) and nitric oxide (DLn...
Objective: Early detection of pulmonary arterial hypertension (PAH) is crucial to improve patient ou...
Pre-capillary pulmonary hypertension (PH) in systemic sclerosis (SSc) is a heterogeneous condition w...
Introduction: Patients with mean pulmonary artery pressures (mPAP) of 21 to 24 mm Hg have a so-calle...
Objective Our goal was to determine if whole blood viscosity (WBV) can be used to predict the risk o...
Background: Pulmonary involvement, manifested as pulmonary arterial hypertension or pulmonary fibros...